336 related articles for article (PubMed ID: 21535319)
1. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
Blondeau K; Boecxstaens V; Van Oudenhove L; Farré R; Boeckxstaens G; Tack J
Neurogastroenterol Motil; 2011 Aug; 23(8):724-e327. PubMed ID: 21535319
[TBL] [Abstract][Full Text] [Related]
2. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
3. Esophageal acid exposure decreases intraluminal baseline impedance levels.
Kessing BF; Bredenoord AJ; Weijenborg PW; Hemmink GJ; Loots CM; Smout AJ
Am J Gastroenterol; 2011 Dec; 106(12):2093-7. PubMed ID: 21844921
[TBL] [Abstract][Full Text] [Related]
4. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
Lacy BE; Chehade R; Crowell MD
Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
[TBL] [Abstract][Full Text] [Related]
5. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
6. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
8. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
Blonski W; Vela MF; Castell DO
J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
[TBL] [Abstract][Full Text] [Related]
9. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
[TBL] [Abstract][Full Text] [Related]
10. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.
Viazis N; Karamanolis GP; Anastasiou J; Keyoglou A; Vlachogiannakos J; Ladas SD; Karamanolis DG
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1450-5. PubMed ID: 24047861
[TBL] [Abstract][Full Text] [Related]
11. Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy.
Garrean CP; Zhang Q; Gonsalves N; Hirano I
Am J Gastroenterol; 2008 Jul; 103(7):1631-7. PubMed ID: 18557714
[TBL] [Abstract][Full Text] [Related]
12. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
13. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
15. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
[TBL] [Abstract][Full Text] [Related]
17. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
[TBL] [Abstract][Full Text] [Related]
18. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
19. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
Desjardin M; Luc G; Collet D; Zerbib F
Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
[TBL] [Abstract][Full Text] [Related]
20. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
